|Quintiles IMS Holdings Inc -- USA Stock|| |
USD 99.48 0.15 0.15%
Mr. Kevin K. Gordon is Executive Vice President and Chief Operating Officer of the Company. effective December 2015. From July 2010 to December 2015 Mr. Gordon served as our Executive Vice President and Chief Financial Officer. Prior to joining us he spent 13 years with Teleflex Incorporated a global publicly traded health care company most recently serving as Executive Vice President and Chief Financial Officer from March 2007 to January 2010. Prior to serving at Teleflex Mr. Gordon spent 12 years in senior finance positions with Package Machinery Company and KPMG
Age: 51 COO Since 2015
Gordon received his Bachelor?s degree in Accounting from the University of Connecticut.
The company has return on total asset of 4.12 %
which means that for every 100 dollars spent on asset it generated profit of $4.12. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE)
of 2.25 %
implying that it made 2.25 on every $100 invested by shareholders.
The company has accumulated 8.97 B in total debt with debt to equity ratio (D/E) of 115.3 implying that the company may be unable to produce cash to meet its debt commitments. Quintiles IMS Holdings Inc has Current Ratio of 1.21 implying that it may have difficulties to pay its interest payments when they become due.
|Found 1 records|
|John Goetz||Bio Rad Laboratories Inc|
Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Quintiles IMS Holdings Inc (Q) is traded on New York Stock Exchange in USA. It is located in NORTH CAROLINA, U.S.A and employs 36,100 people. Quintiles IMS is listed under Business Services category by Fama And French industry classification.